N&O Index Card
Subject/Name: Glaxo Inc.
Article(s) Referenced In:
- Glaxo expects half of sales from Zantac, board told - Ja 9 90 1D
- Glaxo gives $250,000 for art exhibit - Ja 18 90 1B
- Glaxo decides against Durham plant; Firm still plans downtown office building for up to 300 workers - Ja 23 90 1B
- Glaxo executive (Sanders) named director of parent firm - Fe 1 90 5C
- Glaxo develops guide for pharmacy students - Fe 13 90 1D
- Durham school may be bought by Glaxo - Fe 24 90 1B
- Carpeting Glaxo floor huge job for Eatmans - Mr 9 90 7c
- Ulcer drug boosts Glaxo profits - Mr 16 90 7C
- Glaxo adds executive vice president (Ingram) - Mr 17 90 8C
- President honors Glaxo volunteers - Mr 23 90 2B
- Sanford, Helms win tax break for Glaxo - Ap 25 90 1
- Glaxo finds profits in stepped-up effort to lobby Congress - Ap 26 90 1B
- Glaxo to update analysts - My 6 90 1F
- Council agrees to sell school land to Glaxo - Jn 1 90 2B
- Glaxo Holdings close to getting approval for drugs - Jn 1 90 7C
- Glaxo unit president elected to firm's board - Jn 14 90 7C
- Glaxo examines new drug for ulcers - Jn 17 90 4F
- Glaxo to seek approval for migraine treatment - Jn 26 90 1D
- Glaxo Inc. begins work on new training center - Jn 28 90 6C
- Glaxo formally asks FDA to approve drug (sumatriptan for migraine) - Jy 3 90 1D
- Way clear for Glaxo to buy Durham school - Jy 11 90 2B
- Glaxo agrees to cut drug prices for state Medicaid programs - Jy 25 90 5B
- Glaxo, Gilead plan may yield new cancer drugs - Jy 27 90 5C
- Shaw boosts its efforts in sciences - Jy 27 90 5B
- Glaxo parent plans $800 million complex - Au 10 90 5C
- Glaxo buys license from RTI, sells drug - Au 30 90 9C
- Glaxo's 'Sir Paul' center - Se 2 90 1F
- Ulcer drug lifts profits for Glaxo - Se 21 90 7C
- British executive (Sykes) to direct Glaxo RTP center - Oc 4 90 6C
- Glaxo to shift RTP focus from heart research - Oc 11 90 6C
- Glaxo Inc. - A chronology - Oc 14 90 12A
- RTP baby Glaxo grows up; Drug firm crowns decade of growth with new center - Oc 14 90 1
- Amid changes, Glaxo unveils research center - Oc 19 90 6C
- The urban image: A $450 million experiment in productivity; Glaxo's campus hopes to get results from good design - No 4 90 1H
- Glaxo is teller's pet - No 18 90 1F
- Glaxo, FBI foil attempt to sell firm rival's secrets - No 23 90 7C
- Delayed Glaxo decision worries backers of Durham's downtown - No 24 90 1B
- Rival drug giants face secrets deal anew - No 24 90 1B
- Glaxo Canada to help develop, sell cancer and virus treatments - No 29 90 6C
- Glaxo presentation impresses analysts - De 5 90 6C
- Glaxo seeks OK for migraine tablet - De 18 90 1D
See a typo in our data? Let us know and we'll fix it.
Places you might find this article:
Search For This Topic
Help us correct this text for future researchers.
Type your transcription below – don't worry about formatting. Please include the line number you are correcting.
Thank you!